Arthroscopy - 2026-10-12 - Journal Article
Sequential Changes in Angiogenesis After Arthroscopic Superior Capsule Reconstruction Using Fascia Lata Autograft Evaluated by Power Doppler Ultrasound.
Uchida A, Hasegawa A, Noguchi Y, Mihata T
Topics
Key Takeaway
After fascia lata autograft superior capsule reconstruction, 100% of grafts demonstrated angiogenesis by 6 months, with MCID achievement rates of 93.3% for VAS and 100% for ASES scores at 12 months.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study prospectively evaluated sequential vascularization of fascia lata autografts after superior capsule reconstruction (SCR) in 30 patients with irreparable rotator cuff tears using power Doppler ultrasound at 6 weeks and 3, 6, and 12 months. Perigraft angiogenesis peaked early (90% at 6 weeks) then declined to 47% at 12 months, while intra-graft angiogenesis at the greater tuberosity peaked at 3 months (77%) and blood flow volume peaked at 6 months. No significant correlation was found between blood flow metrics and VAS or ASES scores (P=.16–.99), suggesting the vascular response reflects remodeling rather than pain-driven inflammation.
Key Limitation
The absence of a control group or comparison to dermal allograft SCR prevents determining whether this vascularization pattern is specific to fascia lata autograft or universal to SCR grafts.
Original Abstract
PURPOSE
To evaluate sequential changes in angiogenesis after superior capsule reconstruction using fascia lata autograft with power Doppler ultrasound and to investigate the relation between angiogenesis-related findings and clinical outcomes.
METHODS
Thirty patients with irreparable rotator cuff tears who underwent superior capsule reconstruction using a fascia lata autograft were prospectively enrolled. Angiogenesis and blood flow volume in the superficial layered tissue in contact with the bursal side of the graft (perigraft) and within the graft on the greater tuberosity and humeral head were evaluated using Fealy's scoring system with power Doppler ultrasound at 6 weeks and 3, 6, and 12 months postoperatively. Visual analog scale (VAS) score for shoulder pain, Neer and Hawkins tests, and American Shoulder and Elbow Surgeons (ASES) score were evaluated preoperatively and postoperatively. Minimal clinically important difference achievement rates for VAS and ASES scores were also evaluated.
RESULTS
All grafts (100%) showed angiogenesis within the 6-month postoperative period. In the perigraft, the rate of cases with angiogenesis and blood flow scores was highest at 6 weeks and then significantly decreased at 12 months (90%-47%, P = .0003; 1.2-0.6 points, P = .04). Angiogenesis within the graft on the greater tuberosity significantly increased at 3 months (43%-77%, P = .004), with blood flow scores peaking at 6 months (0.3-1.3 points, P = .02). No significant correlations were observed between blood flow and VAS or ASES scores (P = .16-.99) or between angiogenesis and impingement tests (P = .09->.99). Minimal clinically important difference achievement rates were 93.3% for VAS and 100% for ASES scores.
CONCLUSIONS
Overall, the minimal clinically important difference achievement rates were 93.3% for the VAS and 100% for the ASES scores after superior capsule reconstruction. Postoperatively, all grafts displayed progressive angiogenesis and pulsatile blood flow, with volume peaking at 6 months. Notably, these sequential changes in vascularization may represent a physiological graft healing and remodeling process rather than pain-related inflammation.
LEVEL OF EVIDENCE
Level II, prospective cohort study.